Id Biomedical Corp.

News & Analysis

id biomedical corp. - All News and Analysis

• ID Biomedical Corporation of Quebec obtains United States patent.

  - 2009-03-01

  ID Biomedical Corporation of Quebec (Laval, Canada) has patented an adjuvant complex composed of bacterial outer membrane protein proteosomes complexed to bacterial liposaccharide is prepared to contain the component parts under a variety of conditions. The complex can be formulated with antigenic material to...

  Tags: Id Biomedical Corp.

• Market Regulation Services Resumption Notice: ID Biomedical Energy Trust; Crescent Point Limited; Exall Resources.

  - 2005-12-07

  TORONTO, ONTARIO, Dec 7, 2005 CCNMatthews via COMTEX -- The following issues will resume trading today: Company ID Biomedical Crescent Point Exall Resources ...

  Tags: Id Biomedical Corp.

• Q3 Earnings Notification for ID Biomedical Corporation.

  - 2005-11-10

  M2 PRESSWIRE-10 November 2005-www.streetinvesting.com: Q3 Earnings Notification for ID Biomedical CorporationC1994-2005 M2 COMMUNICATIONS LTD RDATE:10112005 Streetinvesting.com Initiates Q3 Earnings Notification for ID Biomedical Corporation(TSX: IDB; NASDAQ: IDBE). They reported financial results for the third quarter of 2005 ended on September...

  Tags: Id Biomedical Corp.

• Zacks.com announces that Nadine Wong highlights: Chiron, Novartis, GlaxoSmithKline, and ID Biomedical

  - 2005-10-06

  CHICAGO -- Nadine Wong, editor of the BioTech Stock Report newsletter, says Chiron (NASDAQ:CHIR) should be motivated to negotiate a price with Novartis (NYSE:NVS). Also, read about GlaxoSmithKline (NYSE:GSK) and ID Biomedical (NASDAQ:IDBE). Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84

  Tags: Chiron Corp., GlaxoSmithKline Plc., Novartis AG

• GlaxoSmithKline to acquire ID Biomedical Corporation.(Industry News)

  - 2005-10-01

  GlaxoSmithKline plc and ID Biomedical Corporation recently announced a definitive agreement for GSK to acquire ID Biomedical, an integrated biotechnology company dedicated to the manufacturing and development of innovative vaccine products, including influenza vaccines. ID Biomedical has facilities in Canada and in the United States....

  Tags: Id Biomedical Corp.

• GlaxoSmithKline Continues Power Play in Hot Global Vaccine Market with $1.4 Billion Buyout Offer for Canada's ID Biomedical

  - 2005-09-23

  HOUSTON -- Researched by Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas). With the flu season fast approaching amidst the not-so-distant memories of last year's vaccine supply fiasco, British drugmaker GlaxoSmithKline plc (http://moneycentral.msn.com/investor/research/profile.asp?Symbol=GSK) (NYSE:GSK) has made a strategic move for growth in the sector.

  Tags: biomedical, GlaxoSmithKline Plc.

• GlaxoSmithKline bids to purchase ID Biomedical

  - 2005-09-20

  GlaxoSmithKline GSK has made a $1.7-billion bid to purchase Vancouver's ID Biomedical IDB, one of Canada's largest biotechnology firms and the primary supplier of the Canadian government's supply of influenza vaccine. The offer has been endorsed by thGlaxoSmithKline GSK has made a $1.7-billion bid to purchase Vancouver's ID Biomedical IDB,...

  Tags: biomedical, GlaxoSmithKline Plc.

• GlaxoSmithKline to purchase ID Biomedical and CytRx says preliminary data show encouraging potential for HIV vaccine.

  - 2005-09-08

  M2 PRESSWIRE-8 September 2005-US Financial Network: GlaxoSmithKline to purchase ID Biomedical and CytRx says preliminary data show encouraging potential for HIV vaccineC1994-2005 M2 COMMUNICATIONS LTD RDATE:08092005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU)...

  Tags: biomedical, FINANCE, financial, GlaxoSmithKline Plc., HEALTHCARE, Nasdaq Stock Market Inc., vaccine

• GlaxoSmithKline of Research Triangle Park has agreed to acquire flu vaccine company ID Biomedical of Vancouver

  - 2005-09-01

  GlaxoSmithKline of Research Triangle Park has agreed to acquire flu vaccine company ID Biomedical of Vancouver, British Columbia, for about $1.4 billion.

  Tags: Id Biomedical Corp.

• Sinovac receives approval for Hepatitis Vaccine and ID Biomedical completes analysis on vaccine.

  - 2005-01-14

  M2 PRESSWIRE-14 January 2005-FNWU: Sinovac receives approval for Hepatitis Vaccine and ID Biomedical completes analysis on vaccineC1994-2005 M2 COMMUNICATIONS LTD RDATE:01142005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). Sinovac Biotech Ltd. (AMEX: SVA)...

  Tags: Id Biomedical Corp.